Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Edlinger Leo |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2024

Originalarbeit (Zeitschrift)

** Edlinger, L In Vivo Modeling of Leukemia by Murine Stem Cell Transplantation.
Methods Mol Biol. 2024; 2773: 1-7. Doi: 10.1007/978-1-0716-3714-2_1
PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Moik, F; Riedl, JM; Edlinger, L; Esterl, T; Hasenleithner, S; Kostmann, S; Cebular, L; Jahn, S; Kashofer, K; Zacharias, M; Hoefler, G; Heitzer, E; Gerger, A; Jost, PJ Practice patterns and treatment outcomes of molecular tumour board (MTB)-based personalized cancer therapies: A single-center experience
ANN ONCOL. 2024; 35: S262-S263. Doi: 10.1016/j.annonc.2024.08.130
Web of Science FullText FullText_MUG

 

2023

Originalarbeit (Zeitschrift)

** Eredics, K; Wehrberger, C; Edlinger, L; Müller, U; Rauchenwald, M; Wehrberger, M; Madersbacher, S Urinary Incontinence, Quality of Life, and Risk Factors in a Geriatric Cohort.
Urol Int. 2023; 1-6. Doi: 10.1159/000531582
Web of Science PubMed FullText FullText_MUG

 

2019

Originalarbeit (Zeitschrift)

** Kollmann, S; Grundschober, E; Maurer, B; Warsch, W; Grausenburger, R; Edlinger, L; Huuhtanen, J; Lagger, S; Hennighausen, L; Valent, P; Decker, T; Strobl, B; Mueller, M; Mustjoki, S; Hoelbl-Kovacic, A; Sexl, V Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia.
Leukemia. 2019; 33(7): 1583-1597. Doi: 10.1038/s41375-018-0369-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Menzl, I; Zhang, T; Berger-Becvar, A; Grausenburger, R; Heller, G; Prchal-Murphy, M; Edlinger, L; Knab, VM; Uras, IZ; Grundschober, E; Bauer, K; Roth, M; Skucha, A; Liu, Y; Hatcher, JM; Liang, Y; Kwiatkowski, NP; Fux, D; Hoelbl-Kovacic, A; Kubicek, S; Melo, JV; Valent, P; Weichhart, T; Grebien, F; Zuber, J; Gray, NS; Sexl, V A kinase-independent role for CDK8 in BCR-ABL1+ leukemia.
Nat Commun. 2019; 10(1): 4741 Doi: 10.1038/s41467-019-12656-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Originalarbeit (Zeitschrift)

** Witalisz-Siepracka, A; Gotthardt, D; Prchal-Murphy, M; Didara, Z; Menzl, I; Prinz, D; Edlinger, L; Putz, EM; Sexl, V NK Cell-Specific CDK8 Deletion Enhances Antitumor Responses.
Cancer Immunol Res. 2018; 6(4): 458-466. Doi: 10.1158/2326-6066.CIR-17-0183
Web of Science PubMed FullText FullText_MUG

 

2017

Originalarbeit (Zeitschrift)

** Edlinger, L; Berger-Becvar, A; Menzl, I; Hoermann, G; Greiner, G; Grundschober, E; Bago-Horvath, Z; Al-Zoughbi, W; Hoefler, G; Brostjan, C; Gille, L; Moriggl, R; Spittler, A; Sexl, V; Hoelbl-Kovacic, A Expansion of BCR/ABL1+ cells requires PAK2 but not PAK1.
Br J Haematol. 2017; 179(2):229-241 Doi: 10.1111/bjh.14833 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

© Med Uni Graz • Impressum